Although MMP-9 has been reported to exert context-dependent neuroprotective effects, such as promoting amyloid-beta clearance in Alzheimer’s disease models (32) our findings suggest that in COPD-associated depression, its pathogenic effects predominate. Here, MMP9 is linked to depressive symptom measurement.